122 related articles for article (PubMed ID: 23845778)
1. Lowered expression levels of a tumor suppressor gene - caveolin-1 within dysregulated gene networks of Fanconi anemia.
Shyamsunder P; Vidyasekar P; Shukla AR; Mohan S; Verma RS
Gene; 2013 Sep; 527(2):521-8. PubMed ID: 23845778
[TBL] [Abstract][Full Text] [Related]
2. Aberrant Fanconi anaemia protein profiles in acute myeloid leukaemia cells.
Xie Y; de Winter JP; Waisfisz Q; Nieuwint AW; Scheper RJ; Arwert F; Hoatlin ME; Ossenkoppele GJ; Schuurhuis GJ; Joenje H
Br J Haematol; 2000 Dec; 111(4):1057-64. PubMed ID: 11167740
[TBL] [Abstract][Full Text] [Related]
3. A novel BTB/POZ transcriptional repressor protein interacts with the Fanconi anemia group C protein and PLZF.
Hoatlin ME; Zhi Y; Ball H; Silvey K; Melnick A; Stone S; Arai S; Hawe N; Owen G; Zelent A; Licht JD
Blood; 1999 Dec; 94(11):3737-47. PubMed ID: 10572087
[TBL] [Abstract][Full Text] [Related]
4. TLR8-dependent TNF-(alpha) overexpression in Fanconi anemia group C cells.
Vanderwerf SM; Svahn J; Olson S; Rathbun RK; Harrington C; Yates J; Keeble W; Anderson DC; Anur P; Pereira NF; Pilonetto DV; Pasquini R; Bagby GC
Blood; 2009 Dec; 114(26):5290-8. PubMed ID: 19850743
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Fanconi Anemia genes in familial breast cancer predisposition.
Seal S; Barfoot R; Jayatilake H; Smith P; Renwick A; Bascombe L; McGuffog L; Evans DG; Eccles D; Easton DF; Stratton MR; Rahman N;
Cancer Res; 2003 Dec; 63(24):8596-9. PubMed ID: 14695169
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of Fanconi anemia genes in sporadic head and neck squamous cell carcinoma.
Wreesmann VB; Estilo C; Eisele DW; Singh B; Wang SJ
ORL J Otorhinolaryngol Relat Spec; 2007; 69(4):218-25. PubMed ID: 17409780
[TBL] [Abstract][Full Text] [Related]
7. FANCC interacts with Hsp70 to protect hematopoietic cells from IFN-gamma/TNF-alpha-mediated cytotoxicity.
Pang Q; Keeble W; Christianson TA; Faulkner GR; Bagby GC
EMBO J; 2001 Aug; 20(16):4478-89. PubMed ID: 11500375
[TBL] [Abstract][Full Text] [Related]
8. The molecular biology of Fanconi anemia.
Tamary H; Bar-Yam R; Zemach M; Dgany O; Shalmon L; Yaniv I
Isr Med Assoc J; 2002 Oct; 4(10):819-23. PubMed ID: 12389351
[TBL] [Abstract][Full Text] [Related]
9. The Fanconi anemia proteins functionally interact with the protein kinase regulated by RNA (PKR).
Zhang X; Li J; Sejas DP; Rathbun KR; Bagby GC; Pang Q
J Biol Chem; 2004 Oct; 279(42):43910-9. PubMed ID: 15299030
[TBL] [Abstract][Full Text] [Related]
10. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.
Hussain S; Witt E; Huber PA; Medhurst AL; Ashworth A; Mathew CG
Hum Mol Genet; 2003 Oct; 12(19):2503-10. PubMed ID: 12915460
[TBL] [Abstract][Full Text] [Related]
11. The vertebrate Hef ortholog is a component of the Fanconi anemia tumor-suppressor pathway.
Mosedale G; Niedzwiedz W; Alpi A; Perrina F; Pereira-Leal JB; Johnson M; Langevin F; Pace P; Patel KJ
Nat Struct Mol Biol; 2005 Sep; 12(9):763-71. PubMed ID: 16116434
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic correction of Fanconi anemia in human hematopoietic cells with a recombinant adeno-associated virus vector.
Walsh CE; Nienhuis AW; Samulski RJ; Brown MG; Miller JL; Young NS; Liu JM
J Clin Invest; 1994 Oct; 94(4):1440-8. PubMed ID: 7929819
[TBL] [Abstract][Full Text] [Related]
13. Changes in protein expression due to deleterious mutations in the FA/BRCA pathway.
Salles D; Cabral RE; Pizzatti L; Bisch PM; Paixão JC; de Almeida CE; Seuánez HN; Cabral-Neto JB
Biochem Biophys Res Commun; 2007 Dec; 364(4):755-60. PubMed ID: 17977515
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of TP53 associated genes in Fanconi anemia cells after mitomycin C and hydroxyurea treatment.
Martinez A; Hinz JM; Gómez L; Molina B; Acuña H; Jones IM; Frias S; Coleman MA
Mutat Res; 2008 Oct; 656(1-2):1-7. PubMed ID: 18647660
[TBL] [Abstract][Full Text] [Related]
15. [Enrichment analysis of Fanconi anemia gene expression profiles in cancer related genesets].
Zhou QQ; Wang XJ; Zhu XF; Yuan WP; Cheng T
Zhonghua Xue Ye Xue Za Zhi; 2012 May; 33(5):371-7. PubMed ID: 22781794
[TBL] [Abstract][Full Text] [Related]
16. Chemosensitizing tumor cells by targeting the Fanconi anemia pathway with an adenovirus overexpressing dominant-negative FANCA.
Ferrer M; de Winter JP; Mastenbroek DC; Curiel DT; Gerritsen WR; Giaccone G; Kruyt FA
Cancer Gene Ther; 2004 Aug; 11(8):539-46. PubMed ID: 15192709
[TBL] [Abstract][Full Text] [Related]
17. Evidence for complete epistasis of null mutations in murine Fanconi anemia genes Fanca and Fancg.
van de Vrugt HJ; Koomen M; Bakker S; Berns MA; Cheng NC; van der Valk MA; de Vries Y; Rooimans MA; Oostra AB; Hoatlin ME; Te Riele H; Joenje H; Arwert F
DNA Repair (Amst); 2011 Dec; 10(12):1252-61. PubMed ID: 22036606
[TBL] [Abstract][Full Text] [Related]
18. p53-dependent pathway of radio-induced apoptosis is altered in Fanconi anemia.
Rosselli F; Ridet A; Soussi T; Duchaud E; Alapetite C; Moustacchi E
Oncogene; 1995 Jan; 10(1):9-17. PubMed ID: 7824283
[TBL] [Abstract][Full Text] [Related]
19. Fanconi anemia C gene product regulates expression of genes involved in differentiation and inflammation.
Zanier R; Briot D; Dugas du Villard JA; Sarasin A; Rosselli F
Oncogene; 2004 Jun; 23(29):5004-13. PubMed ID: 15077170
[TBL] [Abstract][Full Text] [Related]
20. "Dub"bing a tumor suppressor pathway.
Niedzwiedz W; Patel KJ
Cancer Cell; 2005 Feb; 7(2):114-5. PubMed ID: 15710323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
